Clinical Research Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Department of Global Health, University of Amsterdam Faculty of Medicine, Amsterdam, Noord-Holland, The Netherlands.
Arch Dis Child. 2021 Feb;106(2):130-136. doi: 10.1136/archdischild-2020-318913. Epub 2020 Aug 20.
Detection of meningitis is essential to optimise the duration and choice of antimicrobial agents to limit mortality and sequelae. In low and middle-income countries most health facilities lack laboratory capacity and rely on clinical features to empirically treat meningitis.
We conducted a diagnostic validation study to investigate the performance of clinical features (fever, convulsions, irritability, bulging fontanel and temperature ≥39°C) and WHO-recommended signs (drowsiness, lethargy, unconsciousness, convulsions, bulging fontanel, irritability or a high-pitched cry) in discriminating meningitis in young infants.
Retrospective cohort study.
Kilifi County Hospital.
Infants aged <60 days hospitalised between 2012 and 2016.
Definite meningitis defined as positive cerebrospinal fluid (CSF) culture, microscopy or antigen test, or leucocytes ≥0.05 x 10∧9/L.
Of 4809 infants aged <60 days included, 81 (1.7%) had definite meningitis. WHO-recommended signs had sensitivity of 58% (95% CI 47% to 69%) and specificity of 57% (95% CI 56% to 59%) for definite meningitis. Addition of history of fever improved sensitivity to 89% (95% CI 80% to 95%) but reduced specificity to 26% (95% CI 25% to 27%). Presence of ≥1 of 5 previously identified signs had sensitivity of 79% (95% CI 69% to 87%) and specificity of 51% (95% CI 50% to 53%).
Despite a lower prevalence of definite meningitis, the performance of previously identified signs at admission in predicting meningitis was unchanged. Presence of history of fever improves the sensitivity of WHO-recommended signs but loses specificity. Careful evaluation, repeated assessment and capacity for lumbar puncture and CSF microscopy to exclude meningitis in most young infants with potential signs are essential to management in this age group.
为了优化抗生素的使用时长和种类,以降低病死率和减少后遗症,对脑膜炎进行检测至关重要。在中低收入国家,大多数卫生机构缺乏实验室检测能力,只能依靠临床特征来经验性治疗脑膜炎。
我们进行了一项诊断验证研究,旨在调查临床特征(发热、惊厥、易激惹、囟门膨隆和体温≥39°C)和世界卫生组织(WHO)推荐的体征(嗜睡、昏睡、昏迷、惊厥、囟门膨隆、易激惹或尖叫)在鉴别 60 天以下婴儿脑膜炎方面的表现。
回顾性队列研究。
肯尼亚基利菲县医院。
2012 年至 2016 年期间住院的<60 天的婴儿。
明确的脑膜炎定义为脑脊液(CSF)培养、显微镜检查或抗原检测阳性,或白细胞≥0.05x10∧9/L。
在纳入的 4809 名<60 天的婴儿中,81 名(1.7%)患有明确的脑膜炎。WHO 推荐的体征对明确脑膜炎的敏感性为 58%(95%CI 47%至 69%),特异性为 57%(95%CI 56%至 59%)。添加发热病史可将敏感性提高至 89%(95%CI 80%至 95%),但特异性降低至 26%(95%CI 25%至 27%)。存在≥5 种先前确定的体征中的 1 种,其敏感性为 79%(95%CI 69%至 87%),特异性为 51%(95%CI 50%至 53%)。
尽管明确脑膜炎的患病率较低,但入院时先前确定的体征对预测脑膜炎的表现仍保持不变。发热病史的存在提高了 WHO 推荐的体征的敏感性,但降低了特异性。对于大多数有潜在体征的年轻婴儿,仔细评估、反复评估、腰椎穿刺和 CSF 显微镜检查以排除脑膜炎,对该年龄段的治疗至关重要。